FemtoDx
Developer of an at‑home and point‑of‑care biosensor platform based on silicon sensor chips and wafer‑scale semiconductor processing. The platform is designed to provide quantitative, lab‑comparable biomarker measurements from small sample volumes, with rapid time‑to‑result and cloud/EHR connectivity for remote clinician access. The company focuses on biomarker assay development, device engineering, and solutions for chronic disease monitoring, drug safety surveillance, and non‑invasive liver disease diagnosis.
Industries
Nr. of Employees
small (1-50)
Patents
Sealed fluid chamber with through semiconductor vias for biomolecular sensors
US-12287334-B2
View DetailsAdaptive programmable modulation techniques for miniaturized measurement devices
US-12188896-B2
View DetailsSealed fluid chamber with planarization for biomolecular sensors and related methods
US-11796537-B2
View Details
Sealed fluid chamber with through semiconductor vias for biomolecular sensors
US-12287334-B2
View DetailsAdaptive programmable modulation techniques for miniaturized measurement devices
US-12188896-B2
View DetailsSealed fluid chamber with planarization for biomolecular sensors and related methods
US-11796537-B2
View DetailsProducts
At‑home / point‑of‑care reader and single‑use cartridge system (platform in development)
A reader paired with marker‑specific disposable cartridges designed to produce quantitative biomarker results from microliter volumes for at‑home or point‑of‑care testing. Intended to display results locally and transmit data via cloud/EHR connectivity.
At‑home ALT (alanine aminotransferase) monitoring assay (in development)
A quantitative at‑home test for the primary liver injury marker ALT intended to enable remote monitoring of drug‑induced liver injury and liver enzyme trends.
At‑home / point‑of‑care reader and single‑use cartridge system (platform in development)
A reader paired with marker‑specific disposable cartridges designed to produce quantitative biomarker results from microliter volumes for at‑home or point‑of‑care testing. Intended to display results locally and transmit data via cloud/EHR connectivity.
At‑home ALT (alanine aminotransferase) monitoring assay (in development)
A quantitative at‑home test for the primary liver injury marker ALT intended to enable remote monitoring of drug‑induced liver injury and liver enzyme trends.
Services
Partnerships to develop customized biomarker assays and integrate them into a reader+cartridge system for clinical or at‑home use.
Development, optimization and validation of biomarker assays for use on the silicon sensor platform, including stability and performance testing.
Regulatory strategy and operational support for clinical trials and post‑market monitoring through partnerships with contract research organizations.
Coordination with semiconductor foundries and medical device contract manufacturers for sensor fabrication and device production.
Partnerships to develop customized biomarker assays and integrate them into a reader+cartridge system for clinical or at‑home use.
Development, optimization and validation of biomarker assays for use on the silicon sensor platform, including stability and performance testing.
Regulatory strategy and operational support for clinical trials and post‑market monitoring through partnerships with contract research organizations.
Coordination with semiconductor foundries and medical device contract manufacturers for sensor fabrication and device production.
Expertise Areas
- Point‑of‑care and at‑home diagnostics
- Semiconductor biosensor development
- Biomarker assay development and validation
- Drug safety monitoring and clinical trial support
Key Technologies
- Silicon sensor chips
- Label‑free electrical detection
- Nanowire field‑effect sensing
- Multiplexed biomarker assays